(19)

(11)

EP 4 217 001 A1

(12)

(43) Date of publication: 02.08.2023 Bulletin 2023/31 (21) Application number: 21873367.3 (22) Date of filing: 22.09.2021

(51) International Patent Classification (IPC):  A61K 41/00(2020.01) (52) Cooperative Patent Classification (CPC): A61K 45/06; A61K 31/135; A61K 9/0014; A61K 9/006; A61K 9/02   C-Sets: A61K 31/135, A61K 2300/00; (86) International application number: PCT/US2021/051583 (87) International publication number: WO 2022/066791 (31.03.2022 Gazette 2022/13)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 22.09.2020 US 202063081547 P 22.09.2020 US 202063081718 P (71) Applicant: Rythera Therapeutics, Inc. Miami Lakes, FL 33015 (US)	(72) Inventors: HARDY, Reginald, L. Ft. Lauderdale, FL 33308 (US) BRIGELL, Mitchell Belmont, MA 02478 (US) (74) Representative: Engstle, Verena  Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Bankgasse 3 90402 Nürnberg 90402 Nürnberg (DE)